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ABSTRACT: A chemical investigation of leaf and root extracts of Millettia extensa led to the 
isolation and structural elucidation of four new prenylated isoflavones, millexatins G-J (1-4), and 
three new coumaronochromones, millexatins K-M (5-7), along with 16 known compounds. The 
structures of the new compounds were determined on the basis of NMR and MS data. 
Compound 4 is rare isoflavone in having a 2-hydroxyethyl moiety at C-8, whereas the structures 
of compounds 5-7 formally arise from a ring closure through HO-2′ and C-2. The absolute 
configurations at the C-2 and C-3 positions of 5 and 6 were determined from their ECD spectra 
through comparison with those of previously reported compounds. Most of compounds were 
evaluated for the inhibitory effects against nitric oxide (NO) production on RAW264.7 
macrophages and their antibacterial activities. Compounds 18 and 19 inhibited NO production 
with IC50 values of 8.5 and 14.3 M, respectively. Compounds 13 and 14 showed antibacterial 
activity against various Gram-positive bacteria with MIC values ranging from 2-8 μg/mL. 
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Millettia extensa (Benth.) Baker is a tropical medicinal plant belonging to the family 
Leguminoseae. The bark has been used to treat sprains and scabies, whereas the roots have been 
used as a contraceptive and used as a protective medicine for women after childbirth.1 Recently, 
we reported the isolation of prenylated isoflavones from the stems of M. extensa and their 
antibacterial activity.2 To complete the chemical study of this plant as well as continue the 
investigation of the bioactivities of the natural products obtained, seven new compounds (1-7) 
along with 16 known compounds (Chart 1) were isolated and identified from the leaf and root 
extracts of this plant. Most of the isolated compounds were evaluated for their antibacterial 
activities as well as their anti-inflammatory activity by assessing their inhibitory effects on LPS-
induced nitric oxide (NO) production in RAW264.7 macrophages.   
Millexatin G (1) was isolated as a yellow viscous oil and its protonated molecular ion 
peak at m/z 465.1917 ([M + H]+, calcd 465.1913) in the HRESITOFMS corresponded to the 
molecular formula of C27H28O7.  Analysis of the 
13C NMR and DEPT data (Table 2) of 1 
indicated 27 carbon resonances, corresponding to four methyls (δC 27.8 (2), 25.4, and 17.8), two 
methoxy groups (δC 56.3 and 56.2), seven methines (δC 154.1, 127.6, 119.4, 115.1, 114.8, 99.4, 
and 94.4), one sp3 methylene (δC 65.6), 12 quaternary carbons (δC 158.9, 156.8, 156.4, 151.3, 
148.9, 143.0, 137.4, 120.1, 110.4, 105.7, 105.1, and 77.5), and one conjugated carbonyl carbon 
(δC 180.4). The 
1H and 13C NMR spectroscopic data (Tables 1 and 2) showed characteristic 
resonances of a pentaoxygenated isoflavone with a gem-dimethylpyran group [δH/δC 6.73 (1H, d, 
J = 9.9 Hz, H-1′′)/ 115.1, 5.62 (1H, d, J = 9.9 Hz, H-2′′)/127.6, 1.47 (6H, s, H-4′′ and H-5′′)/27.8, 
δC 77.5 (C-3′′)], an isoprenyloxy unit [δH/δC 5.53 (1H, t, J = 6.7 Hz, H-2′′′)/119.4, 4.63 (2H, d, J 
= 6.7 Hz, H-1′′′)/65.6, 1.79 (3H, s, H-4′′′)/25.4, 1.76 (3H, s, H-5′′′)/17.8, δC 137.4 (C-3′′′)], an 
olefinic proton [δH/δC 7.83 (1H, s, H-2)/154.1], and three aromatic protons [δH/δC 6.86 (1H, s, H-
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6′)/114.8, 6.63 (1H, s, H-3′)/99.4, 6.34 (1H, s, H-8)/94.4]. These spectroscopic data were similar 
to those of millexatin C previously isolated from the stem of M. extensa.2 The difference 
between these two compounds was that the OMe-5 substituent of millexatin C was replaced by a 
OH-5 substituent in 1, which displayed a resonance for a H-bonded hydroxy proton at δH 13.20 
(1H, s, OH-5). The NOESY correlations between H-3′ and OMe-2′ (δH 3.76) and H-6′ and OMe-
5′ (δH 3.84) confirmed the locations of these two methoxy groups. The HMBC correlations of 
OH-5 to C-4a (δC 105.7), C-5 (δC 156.4), and C-6 (δC 105.1) and of H-1′′ (δH 6.73) to C-5 (δC 
156.4), C-7 (δC 158.9), and C-3′′ (δC 77.5) (Figure 1) further supported this assignment. 
The HRESITOFMS of millexatin H (2), a yellow viscous oil, exhibited an ion peak at 
m/z 435.1804 [M + H]+ (calcd for C26H27O6, 435.1808), corresponding to the molecular formula 
C26H26O6. The NMR spectroscopic data (Tables 1 and 2) were very close to those of 
isoauriculasin (8),1 except for the disappearance of a H-bonded C-5 hydroxy proton in the 1H 
NMR spectrum of 2. The additional methoxy group (δH 3.89) in 2 was placed at C-5 due to the 
HMBC correlations (Figure 1) between OMe-5 and C-5 (δC 155.3) and between H-1′′ (δH 6.75) 
to C-5 (δC 155.3), C-7 (δC 157.6), and C-3′′ (δC 77.3).  
Millexatin I (3), a yellow viscous oil, gave a protonated molecular formula of C25H25O5, 
which was deduced from its HRESITOFMS data ([M + H]+ m/z 405.1703, calcd 405.1702). 
When a comparison was made of the 1H and 13C NMR spectroscopic data  of 3 (Tables 1 and 2) 
with those of millexatin D (13),2 the major difference found was that compound 3 showed a 
resonance for a H-bonded hydroxy proton at C-5 [δH 13.24 (1H, s) while 13 had a OMe group 
resonance associated with the C-5 position. In addition, the two singlet resonances for the para-
aromatic protons on the B ring of compound 13 were replaced with a set of ABC spin-coupled 
aromatic protons [δH/δC 7.46 (1H, d, J = 1.6 Hz, H-6′)/126.7, 7.37 (1H, d, J = 8.4, 1.6 Hz, H-
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2′)/128.4, and 6.97 (1H, d, J = 8.4 Hz, H-3′)/117.5] in 3. These assignments were supported by 
the HMBC correlations (Figure 1) of OH-5 to C-4a (δC 105.7), C-5 (δC 156.5), and C-6 (δC 
105.1), of H-2′ to C-3 (δC 123.4), C-4′ (δC 154.7), and C-6′ (δC 126.7), and of H-6′ to C-3, C-2′ 
(δC 128.4), C-4′ (δC 154.7), and C-1′′′ (δC 39.9).  
Millexatin J (4) was obtained as a yellow solid that gave a protonated molecular ion peak 
at m/z 397.1292 [M + H]+ (calcd, 397.1287) in its HRESITOFMS, suggesting a molecular 
formula of C22H20O7. The NMR spectroscopic data of 4 (Tables 1 and 2) indicated it to be 
related structurally to auriculatin (16),2 except that compound 4 displayed resonances for a 2-
hydroxylethyl moiety at δH 3.69 (2H, t, J = 7.3 Hz, H-3′′′)/δC 60.7, and 2.95 (2H, t, J = 7.3 Hz, 
H-2′′′)/δC 25.8 instead of prenyl unit as in 16. The location of this group at C-8 was confirmed 
by the HMBC correlations (Figure 1) of H-2′′′ with C-7 (δC 157.1), C-8 (δC 104.5), and C-8a (δC 
155.3).  
Millexatin K (5), a yellow viscous oil, showed a protonated molecular ion peak at m/z 
451.1760 [M + H]+ (calcd for 451.1757) in the HRESITOFMS, corresponding to a molecular 
formula of C26H26O7. Comparison of its 
1H and 13C NMR data (Tables 1 and 2) with those of 
(2R,3S)-3,7,4′-trihydroxy-5-methoxycoumaronochromone3 indicated that the structure of 5 is a 
coumaronochromone derivative. Compound 5 displayed additional resonances for a gem-
dimethylpyran group [δH/δC 6.49 (1H, d, J = 10.0 Hz, H-1′′)/115.0, 5.56 (1H, d, J = 10.0 Hz, H-
2′′)/128.7, 1.41 (3H, s, H-5′′)/27.9, 1.40 (3H, s, H-4′′)/28.2, and δC 78.1], and an isoprenyloxy 
unit [δH/δC 5.42 (1H, t, J = 6.1 Hz, H-2′′′)/118.6, 4.42 (2H, d, J = 6.1 Hz, H-1′′′)/64.8, 1.77 (3H, 
s, H-4′′′)/25.5, 1.71 (3H, s, H-5′′′)/17.8, δC 138.7 (C-3′′′)].  The HMBC correlations of H-1′′ with 
C-5 (δC 156.2), C-6 (δC 110.4), and C-7 (δC 160.5) confirmed the location of the gem-
dimethylpyran unit at C-6/C-7. An isoprenyloxy unit was placed at C-4′ due to the HMBC 
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correlation of H-1′′′ with C-4′ (δC 161.4). The (2R,3S) absolute configuration of 5 was identified 
from the comparison of its ECD spectrum (Figure 2) and specific rotation with those of (2R,3S)-
3,7,4′-trihydroxy-5-methoxycoumaronochromone.3 
The molecular formula of millexatin L (6), a yellow viscous oil, was deduced as 
C26H26O7 based on a sodium adduct molecular ion peak at m/z 459.1422 [M + Na]+ (calcd for 
459.1420) in the HRESITOFMS. The NMR spectroscopic data (Tables 1 and 2) of 6 were 
comparable to those of 5, except that the resonance for the OMe-5 in 5 was replaced by a H-
bonded hydroxy proton resonance in 6 at δH 11.75 (1H, s, OH-5). The (2R,3S) absolute 
configuration of 6 was assigned from a comparison of its ECD spectrum and specific rotation 
with those of 5.  
Millexatin M (7) was isolated as a yellow solid. The molecular formula C25H22O6 was 
deduced from the protonated molecular ion peak at m/z 419.1490 [M + H]+  (calcd for 419.1495) 
in the HRESITOFMS. The NMR spectroscopic data of 7 (Tables 1 and 2) were closely related to 
those of 5 except that compound 7 displayed a resonance for an OH-4 substituent, instead of 
resonances for a 4-oxyprenyl group, and resonances for a prenyl unit at C-8 rather than a 
resonance for an aromatic proton in 5. The HMBC data confirmed the position of the prenyl 
group in 7 at C-8 from the correlation of H-1 with C-8. Additionally, a formal loss of water 
from compound 5 is postulated to generate the Δ2(3) double bond in 7, resulting in two sp2 
carbons at C-2 and C-3.   
The known compounds were identified as isoauriculasin (8),2 5-O-methyl-4′-O-(3-
methyl-2-butenyl)alpinumisoflavone (9),2 2′-deoxyisoauriculatin (10),2 isoauriculatin (11),2 
millexatin B (12),2 millexatin D (13),2 millipurone (14),4 millexatin A (15),2 auriculasin (16),2 
auriculatin (17),2 scandenone (18),2 5,7,3′,4′-tetrahydroxy-6,8-diprenyl isoflavone (19),5 
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millexatin F (20),1 5-hydroxy-7-methoxy-4′-O-(3-methylbut-2-enyl)isoflavone (21),1 7,4′-di-O-
prenylgenistein (22),1 and erycristagallin (23).6  
Nitric oxide (NO), a highly reactive radical, represents an important signaling molecule 
that plays a key role in several physiological and pathological processes.7 This mediator is 
synthesized endogenously mainly under the catalysis of the inducible (i-), constitutive (c-), or 
endothelial (e-) isoforms of nitric oxide synthase (NOS), which catalyze NO and L-citrulline 
formation from O2 and L-arginine.
8 iNOS is a key mediator or regulator in the development and 
progress of different inflammatory diseases and plays a certain role in carcinogenesis.9,10 It has 
become a target for drug development in the treatment of chronic inflammatory diseases.8 Most 
of the isolated compounds (1-7, 9, 15, 17-19, and 21-22) were tested for their NO inhibitory effects 
in RAW264.7 macrophage cells. Among these, compounds 18 and 19 inhibited NO production 
with IC50 values of 8.5 and 14.3 M, respectively, more potently than the positive control, 
indomethacin (IC50 = 62.9 M). None of these compounds showed cytotoxicity at 10 M against 
RAW264.7 macrophage cells (Table S1, Supporting Information). The other compounds were 
not active against NO production. These results suggest that the para-disubstituted aromatic ring 
of 18 might improve inhibition of NO production, compared to compounds 16 and 17. The open 
side chain of the isoprenyl substituent at C-5 and C-6 in 19 seems important for activity when 
compared with 16. 
Thirteen compounds (1-7, 12-14, 19, and 21-22) were tested for their antibacterial 
activities (Table S2, Supporting Information) against Gram-positive (Micrococcus luteus, 
Streptococcus mutans, Staphylococcus epidermidis, Bacillus cereus, and Staphylococcus aureus) 
and Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium, and 
Shigella flexneri) bacteria. Compound 13 showed strong antibacterial activity against B. cereus 
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and S. aureus with the same MIC value of 8 μg/mL, while 14 exhibited more potent antibacterial 
activity against M. luteus, S. epidermidis, and S. aureus with MIC values of 2-4 μg/mL. 
Compound 19 demonstrated more modest antibacterial activities against M. luteus, S. mutans, 
and B. cereus with the same MIC value of 16 μg/mL. All remaining compounds were found to 
have weak activities (MIC 32-128 μg/mL) or no activity against the tested bacterial strains. The 
results of preliminary antibacterial activity suggested that millipurone (14) may has a potential 
as lead compounds for further evaluation and development of antibacterial agents.   
EXPERIMENTAL SECTION 
General Experimental Procedures. The general information on instruments and 
materials was the same as in previous reports.2 
Plant Material. The leaves and roots of M. extensa were collected, identified, and 
deposited as described earlier.2   
Extraction and Isolation. Air-dried leaves of M. extensa (856.6 g) were extracted with 
EtOAc (3 × 6 L, for 3 days) at room temperature. After removal of the solvent by evaporation, 
the crude extract (72.6 g) was subjected to quick column chromatography (QCC) over silica gel 
using a gradient of hexanes-acetone to give seven fractions (LA-LG). Fraction LB (154.6 mg) 
was purified by CC using EtOAc-hexanes (3:17, v/v) to give compounds 1 (1.2 mg), 23 (1.4 
mg), and a sub-fraction LB-1. Sub-fraction LB-1 (77.8 mg) was further separated by CC using 
acetone-hexanes (1:4, v/v) to give 8 (1.7 mg) and 10 (1.9 mg). Fraction LC (2.1 g) was applied 
to a CC eluting with EtOAc-hexanes (3:17, v/v) to afford 9 (2.1 mg), 17 (2.6 mg), and 20 (1.6 
mg). Fraction LE (1.6 g) was similarly subjected to CC using EtOAc-hexanes (3:7, v/v), then 
followed by CC eluting with acetone-hexanes (1:4, v/v) to give 14 (2.8 mg), 16 (324.6 mg), and 
19 (6.0 mg).  Fraction LF (451.3 mg) was subjected to a RP-18 CC using MeOH-H2O (7:3, v/v), 
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then followed by CC eluting with MeOH-CH2Cl2 (1:49, v/v) to yield 2 (4.7 mg) and 15 (0.5 mg). 
Compound 4 (2.5 mg) was isolated from fraction LG (278.7 mg) by Sephadex LH-20 CC with 
100% MeOH and followed by CC using MeOH-CH2Cl2 (1:24, v/v). 
Air-dried roots of M. extensa (3.0 kg) were extracted with EtOAc (3 × 15 L, for 3 days) 
at room temperature. Evaporation of the solvent under reduced pressure to give the EtOAc 
extract (153.8 g). This crude extract was subjected to QCC on silica gel using a gradient of 
hexanes-acetone to provide seven fractions (RA-RG). Fraction RB (7.19 g) was further separated 
by QCC using EtOAc-hexanes (1:49, v/v), then followed by CC eluting with CH2Cl2-hexanes 
(1:9, v/v) to give 10 (13.0 mg) and 22 (10.2 mg). Fraction RD (496.8 mg) was purified by 
Sephadex LH-20 CC with MeOH-CH2Cl2 (8:2, v/v) and followed by CC using acetone-hexanes 
(1:19, v/v) to yield compounds 11 (2.3 mg) and 21 (6.3 mg). Fraction RE (173 mg) was 
subjected to Sephadex LH-20 CC using MeOH-CH2Cl2 (8:2, v/v) to give 18 (12.5 mg). Fraction 
RF (5.6 g) was applied to a QCC eluting with acetone-hexanes (1:9, v/v) to afford 5 (2.0 mg) 
and 12 (49.0 mg). Fraction RG (1.76 g) was applied to Sephadex LH-20 CC with MeOH-CH2Cl2 
(8:2, v/v) and followed by CC using acetone-hexanes (1:4, v/v) to give 3 (1.6 mg), 6 (1.7 mg), 7 
(3.6 mg), and 13 (1.3 mg). 
Millexatin G (1): Yellow viscous oil; UV (CHCl3) λmax (log ) 275 (4.07), 339 (3.87) nm; 
IR (KBr) νmax 3442, 2928, 1654, 1511, 1462 cm
−1; 1H and 13C NMR, see Tables 1 and 2; 
HRESITOFMS m/z 465.1917 [M + H]+ (calcd for C27H29O7, 465.1913). 
Millexatin H (2): Yellow viscous oil; UV (CHCl3) λmax (log ) 220 (3.97), 265 (4.05), 
333 (3.47) nm; IR (KBr) νmax 3384, 2974, 1603, 1509, 1466 cm
−1; 1H and 13C NMR, see Tables 
1 and 2; HRESITOFMS m/z 435.1804 [M + H]+ (calcd for C26H27O6, 435.1808). 
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Millexatin I (3): Yellow viscous oil; UV (CHCl3) λmax (log ) 286 (3.93), 336 (3.32) nm; 
IR (KBr) νmax 3411, 2974, 1607, 1468 cm
−1; 1H and 13C NMR, see Tables 1 and 2; 
HRESITOFMS m/z 405.1703 [M + H]+ (calcd for C25H25O5, 405.1702).  
Millexatin J (4): Yellow solid, mp 190-191 °C; UV (CHCl3) λmax (log ) 257 (3.92), 330 
(3.39) nm; IR (KBr) νmax 3388, 2932, 1652, 1520, 1437 cm
−1; 1H and 13C NMR, see Tables 1 and 
2; HRESITOFMS m/z 397.1292 [M + H]+ (calcd for C22H21O7, 397.1287). 
Millexatin K (5): Yellow viscous oil; [α]22D  − 28 (c 0.1, CHCl3); ECD (c 0.05, CHCl3) 
λmax nm (Δε) 212 (2.91), 236 (−2.00), 262 (0.87), 285 (−0.14); UV (CHCl3) λmax (log ) 237 
(2.89), 284 (2.95) nm; IR (CHCl3) νmax 3435, 2924, 1600, 1470, 1269 cm
−1; 1H and 13C NMR, 
see Tables 1 and 2; HRESITOFMS m/z 451.1760 [M + H]+ (calcd for C26H27O7, 451.1757). 
Millexatin L (6): Yellow viscous oil; [α]22D −36 (c 0.1, CHCl3); ECD (c 0.05, CHCl3) 
λmax nm (Δε) 211 (3.61), 248 (−0.19), 271 (1.22), 323 (−0.34); UV (CHCl3) λmax (log ) 211 
(3.15), 273 (3.39), 322 (3.08) nm; IR (KBr) νmax 3431, 2978, 1623, 1493 cm
−1; 1H and 13C NMR, 
see Tables 1 and 2; HRESITOFMS m/z 459.1422 [M + Na]+ (calcd for C24H30O7Na, 459.1420).  
Millexatin M (7): Yellow solid; mp 249-250 oC; UV (CHCl3) λmax (log ) 247 (3.95), 296 
(4.01), 351 (3.42) nm; IR (CHCl3) νmax 3257, 2920, 1609, 1503, 1424 cm
−1;1H and 13C NMR, 
see Tables 1 and 2; ESITOFMS m/z 419.1490 [M + H]+ (calcd for C25H23O6, 419.1495). 
Nitric Oxide Production Inhibitory Assay. The nitric oxide production in the medium 
was previously described by Joo et al.11 Briefly, RAW 264.7 cells were plated at a density of 5.0 
× 105 cells/mL in 96-well plates and incubated for 24 h at 37 °C and 5% CO2. Then culture 
supernatant of each well was discarded and stimulated with 1 μg/mL LPS in the presence or 
absence of the compounds. After incubation at 37 °C for 24 h, 50 μL of the culture supernatant 
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was incubated with 50 μL of a Griess reagent at room temperature for 10 min. The absorbance 
was measured at 570 nm against a calibration curve with sodium nitrite standards. 
Cell Viability Assay. Cell viability studies were carried out by the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide; Millipore Sigma) assay, as previously 
described.12 
Antibacterial Assay. All bacterial strains used in these experiments were obtained from 
the Microbiological Resources Center, Bangkok, Thailand. The antibacterial assays were 
determined as recommended by Clinical and Laboratory Standards Institute.1315  
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Chart 1.  
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Figure 1. Key HMBC and NOESY correlations for compounds 1-7. 
 
 
 
 
Figure 2. ECD spectra for compounds 5 and 6. 
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Table 1. 1H NMR (600 MHz) Spectroscopic Data of Compounds 1–7 in CDCl3 (δ in ppm, J in Hz)
a 
 
position 1 2 3 4b 5 6 7c 
2 7.83, s 7.76, s 7.88, s 8.19, s 6.31, s 6.30, s  
8 6.34, s 6.60, s 6.39, s  6.23, s 6.00, s  
2′  7.06, br s 7.37, dd (8.4, 1.6) 7.14, d (1.8)    
3′ 6.63, s  6.97, d (8.4)  6.45, d (2.0) 6.61, d (2.0) 7.12, d (2.0) 
5′  6.90, d (8.4)  6.86, d (8.2) 6.47, dd (8.4, 2.0) 6.62, dd (8.5, 2.0) 6.93, dd (8.4, 2.0) 
6′ 6.86, s 7.05, dd (8.4, 2.1) 7.46, d (1.6) 6.92, dd (8.2, 1.8) 7.07, d (8.4) 7.27, d (8.5) 7.72, d (8.4) 
1′′ 6.73, d (9.9) 6.75, d (10.0) 6.78, d (10.0) 6.67, d (10.0) 6.49, d (10.0) 6.60, d (10.1) 6.62, d (10.0) 
2′′ 5.62, d (9.9) 5.73, d (10.0) 5.68, d (10.0) 5.74, d (10.0) 5.56, d (10.0) 5.55, d (10.1) 5.81, d (10.0) 
4′′ 1.47, s 1.47, s 1.53, s 1.47, s 1.40d, s 1.49d, s 1.44, s 
5′′ 1.47, s 1.47, s 1.53, s 1.47, s 1.41d, s 1.44d, s 1.44, s 
1′′′ 4.63, d (6.7) 4.60, d (6.8)  2.95, t (7.3) 4.42, d (6.1) 4.52, d (6.7) 3.37, d (7.3) 
2′′′ 5.53, t (6.7) 5.50, tq (6.8, 1.3) 6.29, dd (17.6, 10.5) 3.69, t (7.3) 5.42, t (6.1) 5.49, t (6.7) 5.18, t (7.3) 
3′′′ 
  
5.45, d (17.6) 
5.40, d (10.5)     
4′′′ 1.79, s 1.80, s 1.54, s  1.77, s 1.84, s 1.82, s 
5′′′ 1.76, s 1.75, s 1.54, s  1.71, s 1.78, s 1.66, s 
OH-3     4.53, s 3.84, s  
OH-5 13.20, s  13.24, s 13.43, s  11.75, s 13.24, s 
OMe-5  3.89, s   3.69, s   
OMe-2′ 3.76, s       
OH-3′  5.68, s      
OH-4′   6.02, s    9.98, s 
OMe-5′ 3.84, s       
a Data of 4 and 7 were measured at 400 MHz. 
b Recorded in acetone-d6  
c Recorded in DMSO-d6  
d Interchangeable 
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Table 2. 13C NMR (150 MHz) Spectroscopic Data of Compounds 1–7 in CDCl3 (δ in ppm)
a 
position 1 2 3 4b 5 6 7c 
2 154.1 150.2 152.1 153.6 109.9 109.1 164.9 
3 120.1 125.1 123.4 122.8 81.1 77.7 97.5 
4 180.4 174.5 180.5 181.3 187.4 191.0 178.8 
4a 105.7 112.8 105.7 105.6 106.7 99.1 104.0 
5 156.4 155.3 156.5 155.2 156.2 157.9 154.9 
6 105.1 112.8 105.1 104.9 110.4 103.4 105.9 
7 158.9 157.6 159.0 157.1 160.5 163.0 155.8 
8 94.4 100.2 94.4 104.5 101.4 96.5 108.0 
8a 156.8 158.2 156.9 155.3 159.6 158.8 151.4 
1′ 110.4 124.7 122.5 122.7 118.0 117.6 113.5 
2′ 151.3 114.8 128.4 116.3 161.4 160.5 150.5 
3′ 99.4 145.3d 117.5 144.7 109.8 109.4 99.1 
4′ 148.9 145.4d 154.7 145.4 161.5 162.1 156.9 
5′ 143.0 111.5 131.7 115.2 96.9 97.5 114.3 
6′ 114.8 120.8 126.7 120.6 123.8 124.4 121.6 
1′′ 115.1 115.7 115.0 115.0 115.0 114.3 115.2 
2′′ 127.6 130.3 127.7 128.3 128.7 126.3 129.5 
3′′ 77.5 77.3 77.6 77.9 78.1 78.4 78.4 
4′′ 27.8 27.9 27.8 27.5 28.2 28.0 28.0 
5′′ 27.8 27.9 27.8 27.5 27.9 28.0 28.0 
1′′′ 65.6 65.4 39.9 25.8 64.8 64.8 21.6 
2′′′ 119.4 118.8 147.1 60.7 118.6 118.5 121.7 
3′′′ 137.4 138.5 113.5  138.7 138.5 131.8 
4′′′ 25.4 25.4 26.4  25.5 25.4 18.2 
5′′′ 17.8 17.8 26.4  17.8 17.8 25.9 
OMe-5  62.4   61.6   
OMe-2′ 56.3       
OMe-5′ 56.2       
a Data of 4 and 7 were measured at 100 MHz. 
b Recorded in acetone-d6  
c Recorded in DMSO-d6 
d Interchangeable 
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